These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8102221)
21. Ki-67 labelling as a proliferation marker in pre-invasive squamous epithelial lesions of cervix. Pahuja S; Choudhury M; Gupta U Indian J Pathol Microbiol; 2003 Jul; 46(3):402-4. PubMed ID: 15025284 [TBL] [Abstract][Full Text] [Related]
22. Proliferation in the normal cervix and in preinvasive cervical lesions. Payne S; Kernohan NM; Walker F J Clin Pathol; 1996 Aug; 49(8):667-71. PubMed ID: 8881920 [TBL] [Abstract][Full Text] [Related]
23. Proliferating cell nuclear antigen in normal urothelium and urothelial lesions of the urinary bladder: a quantitative assessment using a true color image analysis system. Knuechel R; Burgau M; Rueschoff J; Hofstaedter F Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(3):137-44. PubMed ID: 7902171 [TBL] [Abstract][Full Text] [Related]
24. Cervical wart virus infection, intraepithelial neoplasia and carcinoma; an immunohistological study using a panel of monoclonal antibodies. Morris HB; Gatter KC; Pulford K; Haynes P; Charnock M; Taylor-Papadimitriou J; Lane EB; Mason DY Br J Obstet Gynaecol; 1983 Nov; 90(11):1069-81. PubMed ID: 6315048 [TBL] [Abstract][Full Text] [Related]
25. Expression of the proliferating cell nuclear antigen in cervical neoplasia. Raju GC Int J Gynecol Pathol; 1994 Oct; 13(4):337-41. PubMed ID: 7814195 [TBL] [Abstract][Full Text] [Related]
26. Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion. Sawada M; Kanai Y; Arai E; Ushijima S; Ojima H; Hirohashi S Cancer Lett; 2007 Jun; 251(2):211-9. PubMed ID: 17196739 [TBL] [Abstract][Full Text] [Related]
27. Atypical mitotic figures and the mitotic index in cervical intraepithelial neoplasia. Van Leeuwen AM; Pieters WJ; Hollema H; Burger MP Virchows Arch; 1995; 427(2):139-44. PubMed ID: 7582243 [TBL] [Abstract][Full Text] [Related]
28. Proliferating cell nuclear antigen expression and the progression of cervical intraepithelial neoplasia. Lakshmi S; Nair M; Rajalakshmi T; Jayaprakash P; Nair M; Pillai M Oncol Rep; 1996 Nov; 3(6):1195-8. PubMed ID: 21594538 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemistry with antibody to the LA-1 oncogene as a prognostic marker in cervical intraepithelial neoplasia. Terzano P; Martini F; Costa S; Martinelli GN Gynecol Oncol; 1993 Mar; 48(3):317-27. PubMed ID: 8385057 [TBL] [Abstract][Full Text] [Related]
30. Morphometric assessment of the biological potential of human papillomavirus infections in the uterine cervix. Tosi P; Luzi P; Santopietro R; Miracco C; Lio R; Syrjänen S; Mäntyjärvi R; Syrjänen K Appl Pathol; 1988; 6(4):247-57. PubMed ID: 2846018 [TBL] [Abstract][Full Text] [Related]
31. Expression of major histocompatibility class II antigens by Langerhans' cells in cervical intraepithelial neoplasia. Hughes RG; Norval M; Howie SE J Clin Pathol; 1988 Mar; 41(3):253-9. PubMed ID: 2834416 [TBL] [Abstract][Full Text] [Related]
32. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis. Cheville JC; Terrell RB; Cohen MB Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516 [TBL] [Abstract][Full Text] [Related]
33. Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. Zidar N; Gale N; Cör A; Kambic V J Laryngol Otol; 1996 May; 110(5):440-5. PubMed ID: 8762312 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the inmunohistochemical markers PCNA and MIB-1 in the diagnosis of low grade lesions of the uterine cervix]. Sánchez-Rosales M; Osorio-Morales S; Díaz-Araujo F Invest Clin; 2004 Sep; 45(3):213-20. PubMed ID: 15469067 [TBL] [Abstract][Full Text] [Related]
36. The evaluation of PCNA/cyclin expression in cervical intraepithelial lesions. Karakitsos P; Kyroudes A; Apostolaki C; Paizi P; Voulgaris Z; Alekou G; Kyrkou K Gynecol Oncol; 1994 Oct; 55(1):101-7. PubMed ID: 7525424 [TBL] [Abstract][Full Text] [Related]
37. The expression of HLA-DR antigen in cervical neoplasia. Raju GC; Teh M; Wee A Cancer Detect Prev; 1994; 18(5):367-73. PubMed ID: 7812983 [TBL] [Abstract][Full Text] [Related]
38. Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspensions and single cells from the uterine cervix in cervical intraepithelial neoplasia. Jonas SK; Benedetto C; Flatman A; Hammond RH; Micheletti L; Riley C; Riley PA; Spargo DJ; Zonca M; Slater TF Br J Cancer; 1992 Jul; 66(1):185-91. PubMed ID: 1637668 [TBL] [Abstract][Full Text] [Related]
39. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in the uterine cervix and cervical squamous neoplasia. Al-Nafussi AI; Klys HS; Rebello G; Kelly C; Kerr G; Cowie V Int J Gynecol Cancer; 1993 May; 3(3):154-158. PubMed ID: 11578336 [TBL] [Abstract][Full Text] [Related]
40. Langerhans' cells and L1 antigen expression in normal and abnormal squamous epithelium of the cervical transformation zone. Poppe WA; Drijkoningen M; Ide PS; Lauweryns JM; Van Assche FA Gynecol Obstet Invest; 1996; 41(3):207-13. PubMed ID: 8698268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]